US Dietary Supplement Industry In 2023: Little New Expected In NDI Notification Enforcement
Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight concludes series here reporting on supplement sector’s outlook for FDA potentially resolving its protracted struggle with NDI notification requirement.
You may also be interested in...
Senate recognizes “dietary supplements have become a routine part of the lives of millions of individuals in the United States” and “the contributions of the natural product industry to the workforce and economy,” says ‘‘Natural Product Industry Week’’ resolution proposed by Sens. Mike Lee and Kyrsten Sinema.
More time for notifications than current deadline of at least 75 days before NDI-containing product is offered for sale in US doesn’t solve problems with FDA’s management of NDI regulation, say trade groups.
HELP Committee Chairwoman Patty Murray, and ranking member Richard Burr also include supplement registration requirement in discussion draft for reauthorizing FDA’s user fee programs for prescription, generic and biosimilar drugs and medical devices.